Statins and Inflammation

Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms

(2020) Luca Liberale et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Colchicine in Patients with Chronic Coronary Disease

(2020) Stefan M. Nidorf et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

(2019) Jean-Claude Tardif et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bioactive Lipids and Chronic Inflammation: Managing the Fire Within

(2018) Valerio Chiurchiù et al.   Frontiers in Immunology

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

(2018) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

The effects of statin use on inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials

(2018) Reza Tabrizi et al.   PHARMACOLOGICAL RESEARCH

Interleukin-1 Beta as a Target for Atherosclerosis Therapy

(2017) Peter Libby   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

The role of cytokines in the development of atherosclerosis

(2016) A. R. Fatkhullina et al.   BIOCHEMISTRY-MOSCOW

Inflammatory Biomarkers and Atherosclerosis

(2016) Takeshi Soeki et al.   International Heart Journal

Elevated Concentration of Interferon-Inducible Protein of 10 kD (IP-10) Is Associated With Coronary Atherosclerosis

(2015) Toshiyuki Niki et al.   International Heart Journal

Effect of Intensive Statin Therapy on Coronary High-Intensity Plaques Detected by Noncontrast T1-Weighted Imaging

(2015) Teruo Noguchi et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Endothelial microparticles as conveyors of information in atherosclerotic disease

(2014) A. Schiro et al.   ATHEROSCLEROSIS

Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target

(2014) Enrica Golia et al.   Current Atherosclerosis Reports

Effect of Atorvastatin Therapy on Fibrous Cap Thickness in Coronary Atherosclerotic Plaque as Assessed by Optical Coherence Tomography

(2014) Kenichi Komukai et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Innate and Adaptive Inflammation as a Therapeutic Target in Vascular Disease

(2014) Dimitris Tousoulis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy

(2013) Rishi Puri et al.   CIRCULATION

Effect of pitavastatin treatment on changes of plaque volume and composition according to the reduction of high-sensitivity C-reactive protein levels

(2012) Young Joon Hong et al.   Journal of Cardiology

C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease

(2012) Y. Matsuo et al.   European Heart Journal-Cardiovascular Imaging

MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis

(2011) Maarten Hulsmans et al.   FASEB JOURNAL

Update on statin-mediated anti-inflammatory activities in atherosclerosis

(2009) Fabrizio Montecucco et al.   Seminars in Immunopathology

CRP and the risk of atherosclerotic events

(2009) Paolo Calabrò et al.   Seminars in Immunopathology

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE